FDA Defends Abortion Pill Ruling After Suit Sent to Lower Court

The FDA is asking a federal court in Texas to follow the US Supreme Court’s lead after justices’ decided earlier this year to dismiss a case regarding access to abortion medication mifepristone.

The Food and Drug Administration and the Alliance for Hippocratic Medicine in a joint status report filed Monday informed the US District Court for the Northern District of Texas on motions for further proceedings after the Supreme Court decision in June.

The high court’s ruling in FDA v. Alliance for Hippocratic Medicine dealt a blow to anti-abortion doctors and industry associations when the justices unanimously dismissed their case ...